GLP-1 Drugs Aid Weight Loss and Cut Heavy Drinking

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorKavya Nair|Published at:
GLP-1 Drugs Aid Weight Loss and Cut Heavy Drinking
Overview

A small clinical trial in The Lancet suggests semaglutide, a common weight-loss drug, significantly reduces heavy drinking days. Participants on the GLP-1 drug saw a 50% greater reduction in heavy drinking compared to placebo, drastically cutting monthly consumption. This opens new avenues for treating alcohol use disorder, a global health challenge with limited options.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

GLP-1 Drugs Tackle More Than Weight

Weekly semaglutide injections, a leading treatment for obesity, have shown effectiveness in reducing alcohol consumption. A recent randomized controlled trial involving 108 patients found those receiving the drug had roughly 50% fewer heavy drinking days compared to the placebo group.

Key Findings From The Lancet Study

The study, published in The Lancet, tracked participants on semaglutide. Their heavy drinking days dropped from an average of 17 per month to just five. Alcohol consumption also fell sharply, from about 2,200 grams monthly to 650 grams. While the trial was small and lacked long-term data, these results significantly strengthen the case for GLP-1 drugs in treating alcohol use disorder.

Broader Reach for Addiction Treatment

Alcohol use disorder affects millions worldwide, often with limited treatment options that can carry stigma. The possibility that a widely used weight-loss medication could offer an effective new therapy for addiction may change treatment approaches and create new market opportunities for drugmakers.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.